Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neoplasms × Genetic Testing × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 12 Prostatic Neoplasms 9 Colorectal Neoplasms 6 Endometrial Neoplasms 5 Ovarian Neoplasms 4 Colonic Neoplasms 4 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Leukemia, Myeloid, Acute 3 Colorectal Neoplasms, Hereditary Nonpolyposis 3 Brain Neoplasms 3 Urogenital Neoplasms 2 Neoplastic Syndromes, Hereditary 2 Neoplasms, Unknown Primary 2 Neoplasm Metastasis 2 Leukemia, Myelomonocytic, Acute 2 Leukemia, Monocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Leukemia, Eosinophilic, Acute 2 Leukemia, Basophilic, Acute 2 Leukemia 2 Hereditary Breast and Ovarian Cancer Syndrome 2 Hematologic Neoplasms 2 Glioma 2 Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8 1 Tuberous Sclerosis 1 Thyroid Neoplasms 1 Spinal Cord Neoplasms 1 Sarcoma 1

Interventions

Surveys and Questionnaires 98 Exercise 88 Blood Specimen Collection 86 Radiotherapy 60 Gemcitabine 53 Bevacizumab 52 Cisplatin 50 Standard of Care 49 Capecitabine 47 Dexamethasone 44 Cyclophosphamide 44 Carboplatin 44 Docetaxel 41 Paclitaxel 40 Interviews as Topic 40 pembrolizumab 39 Oxaliplatin 38 Methods 35 Irinotecan 35 Fluorouracil 35 Magnetic Resonance Spectroscopy 33 Therapeutics 29 Radiosurgery 28 Nivolumab 27 Drug Therapy 26 Educational Status 25 Leucovorin 22 Everolimus 21 Control Groups 21 Cognitive Behavioral Therapy 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06008392 2025-10-10

INTERCEPTioN

Mayo Clinic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡